Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer. - Wang, De‐shen; Wang, Zhi‐qiang; Chen, Gong; Peng, Jie‐wen; Wang, Wei; Deng, Yan‐hong; Wang, Feng‐hua; Zhang, Jian‐wei; Liang, Han‐lin; Feng, Fen; Xie, Chuan‐bo; Ren, Chao; et al. (Cancer Medicine, 2020)